ClinicalTrials.Veeva

Menu

Evaluation and Refinement of KF-STRIDE Into the Interview!

Kessler Foundation logo

Kessler Foundation

Status

Not yet enrolling

Conditions

Autism Spectrum Disorder

Treatments

Behavioral: KF-STRIDE

Study type

Interventional

Funder types

Other

Identifiers

NCT07168941
E-1238-23

Details and patient eligibility

About

Examine the acceptability, usability, feasibility, and initial efficacy of KF-STRIDE 3.0, the data from which will serve as a basis for a future fully powered RCT

Full description

Although KF-STRIDE 2.0 was designed to support youth on the spectrum, its current design may not be appropriate for adults. Thus, the current proposal will support development activities to significantly adapt KF-STRIDE 2.0 to meet the specific needs of adults with autism. As part of development, we will partner with the autism community, using mixed methodology to ensure our modifications are performed with community-engaged methods. We will invite adults with autism, family members, employers, and vocational counselors to provide feedback to guide the modifications to KF-STRIDE. We will then test the acceptability, feasibility, fidelity, and initial efficacy of KF-STRIDE 3.0 among adults on the spectrum. Obtaining employment is essential to individuals on the spectrum as it can lead to improved community integration, increased social networking, and a means to contribute to society as productive citizens. Overall, we propose to adapt a treatment that has strong potential to help adults with autism improve their job interview skills that will lead to increased employment.

Enrollment

30 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • You live in the United States of America
  • You speak English Fluently and at a 4th grade reading level

Exclusion criteria

  • You have a history of significant psychiatric illness (like bipolar disorder, schizophrenia, or psychosis)
  • You have a history of substance abuse

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

30 participants in 2 patient groups

Kessler Foundation STRength IDentification and Expression (KF-STRIDE)
Experimental group
Treatment:
Behavioral: KF-STRIDE
Services as Usual
No Intervention group

Trial contacts and locations

1

Loading...

Central trial contact

Katarina Reduzzi; Helen Genova

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems